Globe Life (NYSE:GL - Get Free Report) had its price objective lifted by stock analysts at TD Cowen from $215.00 to $218.00 in a research note issued to investors on Monday, Benzinga reports. The brokerage currently has a "buy" rating on the stock. TD Cowen's price target points to a potential upside of 35.34% from the company's previous close.
Several other research firms have also commented on GL. Morgan Stanley decreased their price objective on shares of Globe Life from $208.00 to $197.00 and set an "overweight" rating for the company in a research note on Monday, October 5th. JPMorgan Chase & Co. boosted their target price on Globe Life from $193.00 to $195.00 and gave the stock an "overweight" rating in a research note on Thursday, October 15th. Keefe, Bruyette & Woods reduced their target price on Globe Life from $192.00 to $190.00 and set an "outperform" rating for the company in a report on Friday, July 24th. Piper Sandler lowered Globe Life from an "overweight" rating to a "neutral" rating and reduced their target price for the company from $200.00 to $165.00 in a report on Friday, October 23rd. Finally, Weiss Ratings raised Globe Life from a "buy (b-)" rating to a "buy (b)" rating in a research report on Wednesday, October 21st. Two analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and three have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $184.18.
Check Out Our Latest Research Report on GL
Globe Life Stock Up 0.2%
Shares of NYSE GL traded up $0.34 during trading on Monday, hitting $161.07. The stock had a trading volume of 29,060 shares, compared to its average volume of 545,913. Globe Life has a 12 month low of $129.21 and a 12 month high of $191.55. The company has a debt-to-equity ratio of 0.40, a current ratio of 0.07 and a quick ratio of 0.07. The company has a market capitalization of $12.15 billion, a PE ratio of 10.77 and a beta of 0.47. The firm has a fifty day moving average of $165.66 and a two-hundred day moving average of $160.70.
Globe Life (NYSE:GL - Get Free Report) last announced its earnings results on Wednesday, October 21st. The company reported $4.84 EPS for the quarter, missing the consensus estimate of $4.90 by ($0.06). Globe Life had a net margin of 18.89% and a return on equity of 19.51%. The firm had revenue of $1.60 billion during the quarter, compared to analysts' expectations of $1.56 billion. During the same quarter in the prior year, the company earned $4.81 EPS. The business's revenue for the quarter was up 5.5% on a year-over-year basis. As a group, equities research analysts forecast that Globe Life will post 15.48 EPS for the current fiscal year.
Globe Life announced that its Board of Directors has approved a stock repurchase program on Monday, August 10th that authorizes the company to buy back $2.50 billion in outstanding shares. This repurchase authorization authorizes the company to buy up to 17.7% of its shares through open market purchases. Share repurchase programs are generally an indication that the company's management believes its stock is undervalued.
Insider Buying and Selling
In related news, EVP Robert Hensley sold 10,000 shares of Globe Life stock in a transaction that occurred on Tuesday, September 22nd. The shares were sold at an average price of $170.07, for a total value of $1,700,700.00. Following the sale, the executive vice president owned 12,384 shares of the company's stock, valued at approximately $2,106,146.88. The trade was a 44.67% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Michael Majors sold 14,377 shares of Globe Life stock in a transaction that occurred on Friday, October 23rd. The stock was sold at an average price of $154.48, for a total transaction of $2,220,958.96. Following the completion of the sale, the executive vice president directly owned 39,141 shares in the company, valued at $6,046,501.68. This trade represents a 26.86% decrease in their position. The SEC filing for this sale provides additional information. 2.11% of the stock is owned by corporate insiders.
Hedge Funds Weigh In On Globe Life
Several institutional investors and hedge funds have recently bought and sold shares of GL. Fulcrum Asset Management LLP purchased a new position in shares of Globe Life during the 3rd quarter valued at $33,000. Johnson Financial Group Inc. bought a new position in shares of Globe Life during the 2nd quarter worth $39,000. Jacobi Capital Management LLC bought a new position in shares of Globe Life during the 3rd quarter worth $50,000. Fortitude Family Office LLC increased its holdings in Globe Life by 94.6% in the 3rd quarter. Fortitude Family Office LLC now owns 327 shares of the company's stock worth $54,000 after acquiring an additional 159 shares during the last quarter. Finally, Assetmark Inc. increased its holdings in Globe Life by 42.0% in the 2nd quarter. Assetmark Inc. now owns 426 shares of the company's stock worth $76,000 after acquiring an additional 126 shares during the last quarter. 81.61% of the stock is owned by institutional investors.
About Globe Life
(
Get Free Report)
Globe Life Inc. is a U.S.-based insurance holding company that provides life and supplemental health insurance through its subsidiaries. Its products include term and whole life insurance, Medicare Supplement insurance, and supplemental health coverage such as accident, cancer, and critical illness policies. The company distributes insurance through a mix of exclusive agents, independent agents, and direct marketing. Its operating companies include Globe Life and Accident Insurance Company, American Income Life, Liberty National, Family Heritage Life, and United American.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Globe Life, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.
While Globe Life currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.